Shire Biotech Denmark ApS

CVR 33358008 · Private limited company (ApS) · Dissolved after merger

Shire Biotech Denmark ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry fremstilling af farmaceutiske præparater. The company is no longer active (status: dissolved after merger). 7 annual reports have been published. The latest annual report (31 Dec 2016) shows equity of DKK 2.3m and a net result of DKK 776k.

Company details

CVR number
33358008
Status
Dissolved after merger
Company type
Private limited company (ApS)
Founded
Ceased
Address
Havneholmen 29
1561 København V
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 80k
Employees
0 (2018)
Auditor
Deloitte Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 6
Missing annual reportNo
Negative equityNo
Equity ratio30.0%
Current ratio142%
Moves (last 2 years)1
CEO changes in total8
CEO's previous bankruptcies0
Other companies at the address157
Going-concern uncertaintyNo

Financials and key figures

Financial year20162015
Gross profitDKK 9.1mDKK 9.7m
Net profitDKK 776kDKK 669k
EquityDKK 2.3mDKK 1.6m
Total assetsDKK 7.8mDKK 4.4m
Short-term debtDKK 5.5m–
Tax owedDKK 184k–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2017 – 31 Dec 201787
1 Jan 2016 – 31 Dec 2016153
1 Jan 2015 – 31 Dec 2015153
1 Jan 2014 – 31 Dec 2014149
1 Jan 2013 – 31 Dec 2013175
1 Jan 2012 – 31 Dec 2012159
1 Dec 2010 – 31 Dec 2011179

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPeter Andreas Stakemann
CEOLars Eric Jernestahl
CEOMary Christine Di Marzio
CEOJohn Erik Mattias Bankel
CEOPaul Michael Blanchfield
BoardHelen Alice Lillistone
BoardLars Eric Jernestahl
BoardMichael Thomas Garry
BoardMary Christine Di Marzio
BoardJohn Erik Mattias Bankel
BoardHelen Rosemary Janaway
BoardPaul Michael Blanchfield
BoardJasper Sökeland
BoardAmanda Miller
BoardJacob Fredrik Westin
BoardJohan Åke Östen Pettersson
BoardKerstin Anna-Lena Engvall
Owner (100%)Shire Pharmaceutical Holdings Ireland Limited
Owner (100%)Shire Denmark A/S
AuditorBDO Holding VII, statsautoriseret revisionsaktieselskab
AuditorBDO KOMMUNERNES REVISION, GODKENDT REVISIONSAKTIESELSKAB
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderANPARTSSELSKABET STAKEMANN

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Address history (2 moves)

Havneholmen 29, 1561 København V
Havneholmen 29, 1561 København V
Kronprinsessegade 18, 1306 København K

Former names

Shire Biotech Denmark ApS –
SHIRE DENMARK ApS –
ApS STAKE NR. 1347 –

Employees per year

Number of employees at Shire Biotech Denmark ApS per year5102011: 420112012: 420122013: 520132014: 920142015: 920152016: 720162017: 1020172018: 02018

Other companies at the same address

Similar companies in København

Questions and answers about Shire Biotech Denmark ApS

Has Shire Biotech Denmark ApS gone bankrupt?

No, Shire Biotech Denmark ApS is not registered as bankrupt in the CVR register. Its status is: dissolved after merger.

Who is the auditor of Shire Biotech Denmark ApS?

Shire Biotech Denmark ApS most recently used Deloitte Statsautoriseret Revisionspartnerselskab.

When was Shire Biotech Denmark ApS founded?

Shire Biotech Denmark ApS was founded on 1 December 2010.

What is the equity of Shire Biotech Denmark ApS?

Equity was DKK 2.3m according to the annual report for the period ending 31 December 2016.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.